VV116 400mg Group

DRUG2 trials

Sponsors

Vigonvita Life Sciences

Conditions

Healthy Subjects

Phase 1

Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV116 in Healthy Volunteers

CompletedNCT05201690

Vigonvita Life SciencesHealthy Subjects

Start: 2021-12-14End: 2022-01-23Updated: 2022-02-09

Safety and Pharmacokinetics Study of Single Ascending Doses of VV116 in Healthy Volunteers

CompletedNCT05227768

Vigonvita Life SciencesHealthy Subjects

Start: 2021-11-11End: 2022-01-13Updated: 2022-06-01